Optimum Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.07M | Hold |
13,277
| – | – | 1.22% | 15 |
|
|
2025
Q2 | $2.46M | Sell |
13,277
-292
| -2% | -$54.3K | 1.07% | 17 |
|
|
2025
Q1 | $2.84M | Sell |
13,569
-590
| -4% | -$115K | 1.34% | 14 |
|
|
2024
Q4 | $2.52M | Hold |
14,159
| – | – | 1.11% | 16 |
|
|
2024
Q3 | $2.8M | Sell |
14,159
-450
| -3% | -$84K | 1.21% | 12 |
|
|
2024
Q2 | $2.51M | Sell |
14,609
-15
| -0.1% | -$2.48K | 1.12% | 13 |
|
|
2024
Q1 | $2.66M | Buy |
14,624
+348
| +2% | +$60K | 1.22% | 13 |
|
|
2023
Q4 | $2.21M | Sell |
14,276
-804
| -5% | -$117K | 1.11% | 14 |
|
|
2023
Q3 | $2.25M | Sell |
15,080
-199
| -1% | -$29.2K | 1.15% | 12 |
|
|
2023
Q2 | $2.06M | Sell |
15,279
-780
| -5% | -$114K | 1.01% | 17 |
|
|
2023
Q1 | $2.56M | Sell |
16,059
-1,241
| -7% | -$190K | 1.34% | 10 |
|
|
2022
Q4 | $2.8M | Sell |
17,300
-2,215
| -11% | -$340K | 1.51% | 7 |
|
|
2022
Q3 | $2.62M | Sell |
19,515
-475
| -2% | -$68.2K | 1.41% | 7 |
|
|
2022
Q2 | $3.06M | Buy |
19,990
+60
| +0.3% | +$9.17K | 1.53% | 7 |
|
|
2022
Q1 | $3.23M | Buy |
19,930
+10
| +0.1% | +$1.45K | 1.36% | 11 |
|
|
2021
Q4 | $2.7M | Sell |
19,920
-507
| -2% | -$59.9K | 1.05% | 15 |
|
|
2021
Q3 | $2.2M | Sell |
20,427
-6,889
| -25% | -$787K | 0.93% | 21 |
|
|
2021
Q2 | $3.08M | Sell |
27,316
-4,047
| -13% | -$456K | 0.96% | 17 |
|
|
2021
Q1 | $3.39M | Buy |
31,363
+587
| +2% | +$62.8K | 0.99% | 15 |
|
|
2020
Q4 | $3.3M | Sell |
30,776
-3,044
| -9% | -$293K | 1% | 17 |
|
|
2020
Q3 | $2.96M | Buy |
33,820
+3,011
| +10% | +$283K | 0.99% | 17 |
|
|
2020
Q2 | $3.02M | Buy |
30,809
+5,293
| +21% | +$466K | 1.05% | 16 |
|
|
2020
Q1 | $1.94M | Sell |
25,516
-606
| -2% | -$51.6K | 0.8% | 23 |
|
|
2019
Q4 | $2.31M | Sell |
26,122
-549
| -2% | -$45.6K | 0.69% | 25 |
|
|
2019
Q3 | $2.02M | Sell |
26,671
-1,472
| -5% | -$101K | 0.64% | 29 |
|
|
2019
Q2 | $2.05M | Sell |
28,143
-9,028
| -24% | -$710K | 0.66% | 27 |
|
|
2019
Q1 | $3M | Sell |
37,171
-2,980
| -7% | -$244K | 0.98% | 19 |
|
|
2018
Q4 | $3.7M | Sell |
40,151
-1,046
| -3% | -$92K | 1.27% | 13 |
|
|
2018
Q3 | $3.9M | Sell |
41,197
-672
| -2% | -$63.7K | 1.08% | 16 |
|
|
2018
Q2 | $3.88M | Sell |
41,869
-798
| -2% | -$77.9K | 1.12% | 15 |
|
|
2018
Q1 | $4.04M | Sell |
42,667
-599
| -1% | -$65.8K | 1.19% | 13 |
|
|
2017
Q4 | $4.18M | Sell |
43,266
-1,299
| -3% | -$122K | 1.33% | 10 |
|
|
2017
Q3 | $3.96M | Sell |
44,565
-1,978
| -4% | -$151K | 1.33% | 11 |
|
|
2017
Q2 | $3.38M | Sell |
46,543
-2,028
| -4% | -$136K | 1.17% | 13 |
|
|
2017
Q1 | $3.17M | Sell |
48,571
-850
| -2% | -$53.4K | 1.12% | 15 |
|
|
2016
Q4 | $3.1M | Sell |
49,421
-1,775
| -3% | -$108K | 1.16% | 14 |
|
|
2016
Q3 | $3.23M | Buy |
51,196
+400
| +0.8% | +$25.9K | 1.21% | 11 |
|
|
2016
Q2 | $3.15M | Sell |
50,796
-239
| -0.5% | -$14.6K | 1.22% | 13 |
|
|
2016
Q1 | $2.92M | Sell |
51,035
-71
| -0.1% | -$3.96K | 1.15% | 16 |
|
|
2015
Q4 | $3.03M | Buy |
51,106
+1,476
| +3% | +$85K | 1.17% | 13 |
|
|
2015
Q3 | $2.7M | Buy |
+49,630
| New | +$3.23M | 1.09% | 15 |
|
|
2015
Q1 | $1.64M | Sell |
28,084
-23,234
| -45% | -$1.4M | 0.52% | 41 |
|
|
2014
Q4 | $1.72M | Buy |
51,318
+26,262
| +105% | +$1.66M | 0.55% | 36 |
|
|
2014
Q3 | $1.45M | Sell |
25,056
-3,450
| -12% | -$192K | 0.48% | 48 |
|
|
2014
Q2 | $1.61M | Buy |
28,506
+2,000
| +8% | +$105K | 0.52% | 41 |
|
|
2014
Q1 | $1.36M | Sell |
26,506
-1,207
| -4% | -$61K | 0.51% | 48 |
|
|
2013
Q4 | $1.46M | Sell |
27,713
-1,306
| -5% | -$64.2K | 0.55% | 45 |
|
|
2013
Q3 | $1.3M | Buy |
+29,019
| New | +$1.29M | 0.53% | 50 |
|
Other funds holding ABBV
Optimum Investment Advisors's ABBV Position: Q3 2025 in Review
Optimum Investment Advisors held its AbbVie (ABBV) position steady in Q3 2025 at 13,277 shares worth $3.07M. The position accounts for 1.22% of the portfolio, ranked #15.
Optimum Investment Advisors first reported a position in ABBV in Q3 2013 and has held it in 48 quarters since. The position peaked at $4.18M in Q4 2017. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Optimum Investment Advisors held 13,277 shares of AbbVie worth $3.07M as of Q3 2025.
- Optimum Investment Advisors left its AbbVie share count unchanged in Q3 2025.
- AbbVie made up 1.22% of Optimum Investment Advisors's portfolio in Q3 2025, its #15 holding.
- Optimum Investment Advisors first reported a position in AbbVie in Q3 2013 and has held it in 48 quarters since.
- Optimum Investment Advisors's AbbVie position peaked at $4.18M in Q4 2017.
- 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.